Clinical Oncology Next Generation Sequencing Market Size, Share, Trends, Growth and Forecast 2030
Clinical Oncology Next Generation Sequencing Market By Technology (Whole Genome Sequencing, Whole Exome Sequencing, and Targeted Sequencing & Re-Sequencing), By Workflow (NGS Pre-Sequencing, NGS Sequencing, and NGS Data Analysis), By Application (Screening, Companion Diagnostics, and Others), By End-User (Hospitals, Clinics, Laboratories, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2023 - 2030
Category: Biotechnology Report Format : PDF
Pages: 203 Report Code: ZMR-4906
Published Date: Oct-2023 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1100 Million | USD 8100 Million | 16% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Clinical Oncology Next Generation Sequencing Market, (2023 - 2030) (USD Million)
- 2.2 Global Clinical Oncology Next Generation Sequencing Market : snapshot
- Chapter 3. Global Clinical Oncology Next Generation Sequencing Market - Industry Analysis
- 3.1 Clinical Oncology Next Generation Sequencing Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Surge in healthcare spending will steer the global market surge over the forecast period
- 3.3 Market Restraints
- 3.3.1. Massive costs related to NGS systems can put brakes on the global industry expansion by 2030
- 3.4 Market Opportunities
- 3.4.1. Reduced prices of NGS systems can help market explore new domains of growth globally
- 3.5 Market Challenges
- 3.5.1. Escalating costs of deploying NGS tools can prove to be a huge challenge for the global industry
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Technology
- 3.7.2 Market attractiveness analysis By Workflow
- 3.7.3 Market attractiveness analysis By Application
- 3.7.4 Market attractiveness analysis By End-User
- Chapter 4. Global Clinical Oncology Next Generation Sequencing Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Clinical Oncology Next Generation Sequencing Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Clinical Oncology Next Generation Sequencing Market - Technology Analysis
- 5.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Technology
- 5.1.1 Global Clinical Oncology Next Generation Sequencing Market share, By Technology, 2022 and 2030
- 5.2 Whole Genome Sequencing
- 5.2.1 Global Clinical Oncology Next Generation Sequencing Market by Whole Genome Sequencing, 2023 - 2030 (USD Million)
- 5.3 Whole Exome Sequencing
- 5.3.1 Global Clinical Oncology Next Generation Sequencing Market by Whole Exome Sequencing, 2023 - 2030 (USD Million)
- 5.4 Targeted Sequencing & Re-Sequencing
- 5.4.1 Global Clinical Oncology Next Generation Sequencing Market by Targeted Sequencing & Re-Sequencing, 2023 - 2030 (USD Million)
- 5.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Technology
- Chapter 6. Global Clinical Oncology Next Generation Sequencing Market - Workflow Analysis
- 6.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Workflow
- 6.1.1 Global Clinical Oncology Next Generation Sequencing Market share, By Workflow, 2022 and 2030
- 6.2 NGS Pre-Sequencing
- 6.2.1 Global Clinical Oncology Next Generation Sequencing Market by NGS Pre-Sequencing, 2023 - 2030 (USD Million)
- 6.3 NGS Sequencing
- 6.3.1 Global Clinical Oncology Next Generation Sequencing Market by NGS Sequencing, 2023 - 2030 (USD Million)
- 6.4 NGS Data Analysis
- 6.4.1 Global Clinical Oncology Next Generation Sequencing Market by NGS Data Analysis, 2023 - 2030 (USD Million)
- 6.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Workflow
- Chapter 7. Global Clinical Oncology Next Generation Sequencing Market - Application Analysis
- 7.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Application
- 7.1.1 Global Clinical Oncology Next Generation Sequencing Market share, By Application, 2022 and 2030
- 7.2 Screening
- 7.2.1 Global Clinical Oncology Next Generation Sequencing Market by Screening, 2023 - 2030 (USD Million)
- 7.3 Companion Diagnostics
- 7.3.1 Global Clinical Oncology Next Generation Sequencing Market by Companion Diagnostics, 2023 - 2030 (USD Million)
- 7.4 Others
- 7.4.1 Global Clinical Oncology Next Generation Sequencing Market by Others, 2023 - 2030 (USD Million)
- 7.1 Global Clinical Oncology Next Generation Sequencing Market overview: By Application
- Chapter 8. Global Clinical Oncology Next Generation Sequencing Market - End-User Analysis
- 8.1 Global Clinical Oncology Next Generation Sequencing Market overview: By End-User
- 8.1.1 Global Clinical Oncology Next Generation Sequencing Market share, By End-User, 2022 and 2030
- 8.2 Hospitals
- 8.2.1 Global Clinical Oncology Next Generation Sequencing Market by Hospitals, 2023 - 2030 (USD Million)
- 8.3 Clinics
- 8.3.1 Global Clinical Oncology Next Generation Sequencing Market by Clinics, 2023 - 2030 (USD Million)
- 8.4 Laboratories
- 8.4.1 Global Clinical Oncology Next Generation Sequencing Market by Laboratories, 2023 - 2030 (USD Million)
- 8.5 Others
- 8.5.1 Global Clinical Oncology Next Generation Sequencing Market by Others, 2023 - 2030 (USD Million)
- 8.1 Global Clinical Oncology Next Generation Sequencing Market overview: By End-User
- Chapter 9. Clinical Oncology Next Generation Sequencing Market - Regional Analysis
- 9.1 Global Clinical Oncology Next Generation Sequencing Market Regional Overview
- 9.2 Global Clinical Oncology Next Generation Sequencing Market Share, by Region, 2022 & 2030 (USD Million)
- 9.3. North America
- 9.3.1 North America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.3.1.1 North America Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.3.1 North America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 North America Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 North America Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 North America Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 North America Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 North America Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 North America Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 North America Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 North America Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- 9.4. Europe
- 9.4.2 Europe Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4.2.1 Europe Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.4.2 Europe Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 Europe Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 Europe Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 Europe Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 Europe Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 Europe Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 Europe Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 Europe Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 Europe Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- 9.5. Asia Pacific
- 9.5.3 Asia Pacific Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.5.3.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.5.3 Asia Pacific Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 Asia Pacific Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- 9.6. Latin America
- 9.6.4 Latin America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.6.4.1 Latin America Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.6.4 Latin America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 Latin America Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 Latin America Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 Latin America Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 Latin America Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 Latin America Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 Latin America Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 Latin America Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 Latin America Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- 9.7. The Middle-East and Africa
- 9.7.5 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.7.5.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Country, 2023 - 2030 (USD Million)
- 9.7.5 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 9.4 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030
- 9.4.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Technology, 2023 - 2030 (USD Million)
- 9.5 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030
- 9.5.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Workflow, 2023 - 2030 (USD Million)
- 9.6 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030
- 9.6.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by Application, 2023 - 2030 (USD Million)
- 9.7 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030
- 9.7.1 The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, by End-User, 2023 - 2030 (USD Million)
- Chapter 10. Company Profiles
- 10.1 Agilent
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Beijing Genomics Institute (BGI)
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Qiagen NV
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Oxford Nanopore Technologies Ltd.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Caris Life Sciences
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Eurofins Scientific
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Perkin Elmer Inc.
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Foundation Medicine
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Myriad Genetics
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Partek Inc.
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Pacific Bioscience Inc.
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Paradigm Diagnostics Inc.
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Thermo Fisher Scientific Corporation
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 and others.
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.1 Agilent
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global Clinical Oncology Next Generation Sequencing Market attractiveness, By Technology
- 6. Global Clinical Oncology Next Generation Sequencing Market attractiveness, By Workflow
- 7. Global Clinical Oncology Next Generation Sequencing Market attractiveness, By Application
- 8. Global Clinical Oncology Next Generation Sequencing Market attractiveness, By End-User
- 9. Global Clinical Oncology Next Generation Sequencing Market share by Technology, 2023 and 2030 (USD Million)
- 10. Global Clinical Oncology Next Generation Sequencing Market by Whole Genome Sequencing, 2023 - 2030 (USD Million)
- 11. Global Clinical Oncology Next Generation Sequencing Market by Whole Exome Sequencing, 2023 - 2030 (USD Million)
- 12. Global Clinical Oncology Next Generation Sequencing Market by Targeted Sequencing & Re-Sequencing, 2023 - 2030 (USD Million)
- 13. Global Clinical Oncology Next Generation Sequencing Market share by Workflow, 2023 and 2030 (USD Million)
- 14. Global Clinical Oncology Next Generation Sequencing Market by NGS Pre-Sequencing, 2023 - 2030 (USD Million)
- 15. Global Clinical Oncology Next Generation Sequencing Market by NGS Sequencing, 2023 - 2030 (USD Million)
- 16. Global Clinical Oncology Next Generation Sequencing Market by NGS Data Analysis, 2023 - 2030 (USD Million)
- 17. Global Clinical Oncology Next Generation Sequencing Market share by Application, 2023 and 2030 (USD Million)
- 18. Global Clinical Oncology Next Generation Sequencing Market by Screening, 2023 - 2030 (USD Million)
- 19. Global Clinical Oncology Next Generation Sequencing Market by Companion Diagnostics, 2023 - 2030 (USD Million)
- 20. Global Clinical Oncology Next Generation Sequencing Market by Others, 2023 - 2030 (USD Million)
- 21. Global Clinical Oncology Next Generation Sequencing Market share by End-User, 2023 and 2030 (USD Million)
- 22. Global Clinical Oncology Next Generation Sequencing Market by Hospitals, 2023 - 2030 (USD Million)
- 23. Global Clinical Oncology Next Generation Sequencing Market by Clinics, 2023 - 2030 (USD Million)
- 24. Global Clinical Oncology Next Generation Sequencing Market by Laboratories, 2023 - 2030 (USD Million)
- 25. Global Clinical Oncology Next Generation Sequencing Market by Others, 2023 - 2030 (USD Million)
- 26. Global Clinical Oncology Next Generation Sequencing Market share, by Region, 2023 and 2030
- 27. North America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 28. Europe Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 29. Asia Pacific Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 30. Latin America Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
- 31. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market, 2023 - 2030 (USD Million)
Table Of Tables
- 1. Global Clinical Oncology Next Generation Sequencing Market: Snapshot
- 2. Drivers of the Clinical Oncology Next Generation Sequencing Market: impact analysis
- 3. North America Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 4. North America Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 5. North America Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 6. North America Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 7. U.S. Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 8. U.S. Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 9. U.S. Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 10. U.S. Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 11. Canada Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 12. Canada Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 13. Canada Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 14. Canada Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 15. Europe Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 16. Europe Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 17. Europe Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 18. Europe Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 19. Germany Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 20. Germany Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 21. Germany Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 22. Germany Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 23. France Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 24. France Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 25. France Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 26. France Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 27. U.K. Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 28. U.K. Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 29. U.K. Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 30. U.K. Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 31. Italy Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 32. Italy Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 33. Italy Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 34. Italy Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 35. Spain Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 36. Spain Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 37. Spain Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 38. Spain Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 39. Rest of Europe Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 40. Rest of Europe Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 41. Rest of Europe Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 42. Rest of Europe Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 43. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 44. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 45. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 46. Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 47. China Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 48. China Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 49. China Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 50. China Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 51. Japan Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 52. Japan Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 53. Japan Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 54. Japan Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 55. India Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 56. India Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 57. India Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 58. India Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 59. South Korea Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 60. South Korea Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 61. South Korea Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 62. South Korea Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 63. South-East Asia Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 64. South-East Asia Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 65. South-East Asia Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 66. South-East Asia Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 67. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 68. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 69. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 70. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 71. Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 72. Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 73. Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 74. Latin America Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 75. Brazil Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 76. Brazil Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 77. Brazil Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 78. Brazil Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 79. Mexico Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 80. Mexico Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 81. Mexico Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 82. Mexico Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 83. Rest of Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 84. Rest of Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 85. Rest of Latin America Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 86. Rest of Latin America Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 87. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 88. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 89. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 90. The Middle-East and Africa Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 91. GCC Countries Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 92. GCC Countries Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 93. GCC Countries Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 94. GCC Countries Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 95. South Africa Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 96. South Africa Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 97. South Africa Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 98. South Africa Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
- 99. Rest of Middle-East Africa Clinical Oncology Next Generation Sequencing Market revenue, By Technology, 2023 - 2030 (USD Million)
- 100. Rest of Middle-East Africa Clinical Oncology Next Generation Sequencing Market revenue, By Workflow, 2023 - 2030 (USD Million)
- 101. Rest of Middle-East Africa Clinical Oncology Next Generation Sequencing Market revenue, By Application, 2023 - 2030 (USD Million)
- 102. Rest of Middle-East Africa Clinical Oncology Next Generation Sequencing Market revenue, By End-User, 2023 - 2030 (USD Million)
Methodology
FrequentlyAsked Questions
With genomics-focused pharmacology beginning to play a major role in cancer therapy, clinical next-generation sequencing (NGS) is emerging as a valuable method for obtaining an in-depth and accurate look into individual tumor molecular backgrounds.
The global clinical oncology next generation sequencing market growth can be owing to technological innovations and a rise in healthcare expenditure.
According to a study, the global clinical oncology next generation sequencing industry size was $1100 million in 2022 and is projected to reach $8100 million by the end of 2030.
The global clinical oncology next generation sequencing market is anticipated to record a CAGR of nearly 16% from 2023 to 2030.
The Asia-Pacific clinical oncology next generation sequencing industry is set to register the highest CAGR over the forecasting timeline owing to low costs of sequencing and supportive government guidelines. High investments by manufacturers will further add to the regional market growth in the coming years.
The global clinical oncology next generation sequencing market is led by players such as Agilent, Beijing Genomics Institute (BGI), Qiagen NV, Oxford Nanopore Technologies Ltd., Caris Life Sciences, Eurofins Scientific, Perkin Elmer, Inc., Foundation Medicine, Myriad Genetics, Partek, Inc., Pacific Bioscience, Inc., Paradigm Diagnostics, Inc., and Thermo Fisher Scientific Corporation.
The clinical oncology next generation sequencing market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.
Choose License Type
List of Contents
Clinical Oncology Next Generation SequencingIndustry Prospective:OverviewKey InsightsGrowth FactorsRestraintsOpportunitiesChallengesSegmentationReport ScopeRegional InsightsCompetitive SpaceThe global clinical oncology next generation sequencing market is segmented as follows:By Region
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed